A detailed history of Kestra Advisory Services, LLC transactions in Opko Health, Inc. stock. As of the latest transaction made, Kestra Advisory Services, LLC holds 50,307 shares of OPK stock, worth $82,503. This represents 0.0% of its overall portfolio holdings.

Number of Shares
50,307
Previous 50,282 0.05%
Holding current value
$82,503
Previous $62,000 19.35%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$1.21 - $1.68 $30 - $42
25 Added 0.05%
50,307 $74,000
Q4 2023

Feb 14, 2024

BUY
$1.23 - $1.63 $1,230 - $1,630
1,000 Added 2.03%
50,282 $75,000
Q3 2023

Nov 09, 2023

BUY
$1.5 - $2.17 $73,923 - $106,941
49,282 New
49,282 $78,000
Q1 2023

May 12, 2023

BUY
$1.06 - $1.61 $1,060 - $1,610
1,000 Added 8.71%
12,476 $18,000
Q4 2022

Jan 31, 2023

SELL
$1.05 - $2.01 $4,410 - $8,442
-4,200 Reduced 26.79%
11,476 $14,000
Q3 2022

Nov 01, 2022

SELL
$1.81 - $2.81 $63,078 - $97,928
-34,850 Reduced 68.97%
15,676 $30 Million
Q2 2022

Aug 12, 2022

BUY
$2.33 - $3.61 $20,713 - $32,092
8,890 Added 21.35%
50,526 $128,000
Q1 2022

Apr 26, 2022

BUY
$2.87 - $4.93 $861 - $1,479
300 Added 0.73%
41,636 $143,000
Q4 2021

Jan 20, 2022

BUY
$3.52 - $5.15 $39,635 - $57,989
11,260 Added 37.44%
41,336 $198,000
Q3 2021

Oct 19, 2021

BUY
$3.44 - $4.24 $890 - $1,098
259 Added 0.87%
30,076 $109,000
Q2 2021

Jul 28, 2021

SELL
$3.33 - $4.55 $2,860 - $3,908
-859 Reduced 2.8%
29,817 $120,000
Q1 2021

May 10, 2021

SELL
$4.19 - $5.99 $36,599 - $52,322
-8,735 Reduced 22.16%
30,676 $131,000
Q4 2020

Jan 20, 2021

BUY
$3.27 - $4.87 $72,793 - $108,411
22,261 Added 129.8%
39,411 $159 Million
Q3 2020

Nov 12, 2020

BUY
$2.99 - $5.96 $51,278 - $102,214
17,150 New
17,150 $63 Million

Others Institutions Holding OPK

About OPKO HEALTH, INC.


  • Ticker OPK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 771,960,000
  • Market Cap $1.27B
  • Description
  • OPKO Health, Inc., a healthcare company, engages in the diagnostics and pharmaceuticals businesses in the United States, Ireland, Chile, Spain, Israel, Mexico, and internationally. The company's Diagnostics segment operates BioReference Laboratories that offers laboratory testing services for the detection, diagnosis, evaluation, monitoring, and...
More about OPK
Track This Portfolio

Track Kestra Advisory Services, LLC Portfolio

Follow Kestra Advisory Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kestra Advisory Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kestra Advisory Services, LLC with notifications on news.